Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

10.1245/ASO.2006.03.042
Annals of Surgical Oncology 13:96-102 (2006)
© 2006 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Duffy, A.
Right arrow Articles by Chen, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Duffy, A.
Right arrow Articles by Chen, H.

Original Article

Long-Term Outcomes in Patients With Calciphylaxis From Hyperparathyroidism

Allison Duffy, MD, Michael Schurr, MD, FACS, Thomas Warner, MD and Herbert Chen, MD, FACS

Section of Endocrine Surgery, Department of Surgery and Department of Pathology, University of Wisconsin-Madison, H4/750 Clinical Science Center, 600 Highland Avenue, Madison, Wisconsin 53792-7375

Correspondence: Address correspondence and reprint requests to: Herbert Chen, MD, FACS; E-mail: chen{at}surgery.wisc.edu.

Background: Calciphylaxis is a rare condition associated with chronic renal failure and entails a very poor prognosis. Pathogenesis is poorly understood but involves abnormalities in calcium and phosphorus metabolism that lead to vascular and extravascular calcification. Patients present with painful ulcerating plaques that progress to gangrenous wounds. Parathyroidectomy has been advanced as a life-saving intervention in these patients, but long-term results with wound healing and survival after parathyroidectomy are not well described.

Methods: Between January 1987 and October 2003, 15 patients with biopsy-confirmed calciphylaxis were treated at the University of Wisconsin. Of these 15 patients, 9 were treated with medical therapy (bisphosphonates and phosphate binders), whereas 6 underwent parathyroidectomy. The medical records were reviewed, and patients or relatives were interviewed. Survival was determined by Kaplan-Meier analysis.

Results: Four patients underwent subtotal parathyroidectomy, and two patients underwent total parathyroidectomy. All had reductions in the intact parathyroid hormone level (mean ± SD, 25.2 ± 4.5 pg/mL). Whereas all six patients treated with parathyroidectomy had partial/complete wound healing, only two of nine in the medical group had any improvements in the skin lesions (P = .006). With up to 80 months of follow-up, patients who underwent parathyroidectomy had a longer median survival compared with those who did not have surgery (39 vs. 3 months; P = .017).

Conclusions: On the basis of our long-term follow-up of this patient population, subtotal or total parathyroidectomy was associated with long-term survival and was more likely to promote healing if performed earlier in the course of disease. Therefore, patients with calciphylaxis from secondary hyperparathyroidism should be referred promptly for potential parathyroidectomy.

Key Words: Calciphylaxis • Secondary hyperparathyroidism • Calcific uremic arteriolopathy • Parathyroidectomy • Wound care




This article has been cited by other articles:


Home page
Am J Health Syst PharmHome page
C. B. Raymond and L. D. Wazny
Sodium thiosulfate, bisphosphonates, and cinacalcet for treatment of calciphylaxis
Am. J. Health Syst. Pharm., August 1, 2008; 65(15): 1419 - 1429.
[Abstract] [Full Text] [PDF]


Home page
INT J LOW EXTREM WOUNDSHome page
U. Wollina, C. Helm, G. Hansel, A. Koch, J. Schonlebe, G. Haroske, and E. Kostler
Deep Ulcer Shaving Combined With Split-Skin Transplantation in Distal Calciphylaxis
International Journal of Lower Extremity Wounds, June 1, 2008; 7(2): 102 - 107.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Society of Surgical Oncology.